Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Stockland (SGP.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (A$)	Price Target (A$)	Rating
2022-04-11	4.23	5.11	Buy
2022-06-20	3.69	4.39	Buy
2022-08-01	3.89	4.30	Buy
2022-08-19	3.73	4.41	Buy
2023-02-22	3.81	4.31	Buy
2023-06-20	4.29	4.25	Neutral
2023-08-24	4.22	4.38	Neutral
2023-12-19	4.40	4.52	Neutral
2024-02-22	4.59	4.64	Neutral
2024-07-05	4.26	4.58	Neutral
2024-08-23	4.93	4.70	Neutral
2024-09-24	5.28	5.32	Neutral
2025-02-20	5.14	5.37	Neutral
2025-06-20	5.60	5.55	Neutral

Disclosures

UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.